Revelation Pharma Acquires Taylors Pharmacy and Key Compounding Pharmacy

Revelation Pharma (Osceola Capital) Acquires Five Compounding Pharmacies

January 27, 2022

Healthcare Services

Revelation Pharma, a PE-backed specialty pharmacy platform sponsored by Osceola Capital, completed add-on acquisitions of five compounding pharmacies: Innovation Compounding, Pencol Compounding Pharmacy, Pharmacy Specialists Compounding, Wise Pharmacy, and Convex Pharmacy. The deals expand Revelation's geographic footprint and clinical capabilities across key U.S. regions and will see some locations merged into existing Revelation businesses (e.g., Wise into Pencol; Convex into Everwell).

Revelation Pharma Acquires Cascade Specialty Pharmacy

January 22, 2025

Healthcare Services

Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Cascade Specialty Pharmacy of Poulsbo, Washington. The acquisition expands Revelation Pharma's ENT and animal-health compounding capabilities and brings Cascade's existing customers and product lines into Revelation's national fulfillment network; Cascade's former owner Brandon Knott will remain involved as an ENT Allergy Product Specialist.

Revelation Pharma Acquires Acacia Apothecary & Wellness

October 9, 2025

Healthcare Services

Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Acacia Apothecary & Wellness, a Tucson-based compounding pharmacy. The deal expands Revelation's footprint and expertise in hormone therapy, women's health, and personalized medicine; Acacia founder Justin Brock, PharmD, will join Revelation as an Operational Consultant.

Revelation Pharma (Osceola Capital) Acquires Eagle Pharmacy and Lee Silsby Compounding Pharmacy

July 13, 2023

Healthcare Services

Osceola Capital’s platform company Revelation Pharma acquired Eagle Pharmacy (Hoover, Alabama) and Lee Silsby Compounding Pharmacy (Beachwood, Ohio), marking the seventeenth and eighteenth add-ons to the Revelation platform. The acquisitions expand Revelation’s 503A/503B compounding capabilities and geographic reach, adding scale, diversification, and capacity to serve patients, prescribers, and healthcare facilities nationwide.

Osceola Capital-Backed Revelation Pharma Acquires Everwell Specialty Pharmacy

March 23, 2021

Healthcare Services

Osceola Capital formed Revelation Pharma Corp as a pharmacy compounding platform in partnership with industry veteran Jacob Beckel and concurrently completed the acquisition of Pensacola-based Everwell Specialty Pharmacy. Revelation will pursue consolidation of 503A compounding pharmacies nationally, with Everwell serving as the initial platform asset focused on anti-infectives, specialty compounding and other therapeutic classes.

Revelation Pharma (Osceola Capital) Acquires Harrow Health's Non‑Ophthalmic Compounding Business

October 12, 2022

Healthcare Services

Osceola Capital-backed Revelation Pharma has acquired the non-ophthalmic compounding business of NASDAQ-listed Harrow Health as the twelfth add-on to the Revelation platform. The deal lets Revelation expand its national footprint of 503A and 503B compounding pharmacies while Harrow focuses solely on ophthalmic medications.